MIRA Pharmaceuticals (NASDAQ:MIRA)

PRESS RELEASE

published on 07/22/2024 at 14:00, 1 year 9 months ago

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA Pharmaceuticals reveals new promising preclinical data for Ketamir-2, a novel oral ketamine analog, indicating potential advantages for treating neurological and neuropsychiatric disorders

Preclinical Study Neurological Disorders MIRA Pharmaceuticals Neuropsychiatric Disorders Ketamir-2
BRIEF

published on 07/15/2024 at 13:05, 1 year 10 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC

Pharmaceuticals Preclinical Studies MIRA-55 Anxiety Treatment THC Comparison
BRIEF

published on 07/15/2024 at 13:05, 1 year 10 months ago

Mira Pharmaceuticals annonce des résultats prometteurs pour MIRA-55 dans plusieurs tests précliniques par rapport au THC

Médicaments Etudes Précliniques MIRA-55 Traitement De L'anxiété Comparaison Du THC
PRESS RELEASE

published on 07/15/2024 at 13:00, 1 year 10 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects

Neurological Disorders Preclinical Studies MIRA-55 MIRA Pharmaceuticals Neuropsychiatric Disorders

Published on 05/18/2026 at 08:01, 1 hour 52 minutes ago

Result of Fundraise
Published on 05/17/2026 at 15:20, 18 hours 33 minutes ago

China XLX Announces 2026 Q1 Results
Published on 05/16/2026 at 01:15, 2 days 8 hours ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 2 days 8 hours ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 2 days 9 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate

View all ACCESSWIRE

Published on 05/18/2026 at 09:26, 26 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 05/18/2026 at 09:22, 30 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 05/18/2026 at 09:10, 43 minutes ago

Unionfab Reduces Low-Volume Metal Parts Production from 30 Days to as Fast as 5 Days
Published on 05/18/2026 at 09:05, 48 minutes ago

iON Race Delivers Controlled Performance Across Monaco's Iconic Double-Header
Published on 05/18/2026 at 09:05, 48 minutes ago

CHERY Officially Announces Robert Lewandowski as CHERY Brand Global Ambassador, Reinforcing the Global Expression of the "For Family" Brand Philosophy

View all EQS

Published on 05/18/2026 at 08:30, 1 hour 23 minutes ago

Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Published on 05/18/2026 at 08:30, 1 hour 23 minutes ago

Thales nomme Jérémie Papin Directeur général, Finance et Systèmes d’Information
Published on 05/15/2026 at 15:08, 2 days 18 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 18 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 23 hours ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.

View all LES ECHOS COMFI WIRE

News